Insight in Asia-Pacific

The following industries match your search criteria:

Published within

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Brief
Brief

Coconut Water Case Study: Consolidating Growth in a Burgeoning Segment

Assesses the market development of a high growth non-alcoholic drinks segment in the US and what leading category players are doing to consolidate their market position

Published By Datamonitor
30 Nov 2010 $400
Buy
Report
Report

Commercial Insight: Antidiabetics in China - Rising patient numbers and novel products drive the future market

Discussion of the Chinese diabetes market including epidemiology, market drivers, and strategic analysis of key players. Assessment of marketed and pipeline products. Commercial forecast of market size and product sales and volumes to 2019.

Published By Datamonitor
21 Feb 2011 $2800
Buy
Report
Report

Commercial Insight: Antidiabetics in India - Growth in the Indian diabetes market will be driven by an increase in diagnosis and the uptake of novel drugs

Discussion of the Indian diabetes market including epidemiology, market drivers, and strategic analysis of key players. Assessment of marketed and pipeline products. Commercial forecast of market size and product sales and volumes to 2019.

Published By Datamonitor
21 Mar 2011 $2800
Buy
Report
Report

Commercial Insight: Asthma/COPD in Australia

In-depth overview and 10 year outlook for currently marketed and pipeline asthma/COPD products in Australia, examining both clinical and commercial factors driving product differentiation and uptake.

Published By Datamonitor
20 May 2010 $5700
Buy
Report
Report

Commercial Insight: Disease Modification in Rheumatoid Arthritis – Market awaits game changing therapies and strategies

Coverage of disease-modifying drugs in the seven major rheumatoid arthritis markets, including indication-specific 10-year forecasts (using both sales and patient-based approaches), detailed brand profiling and an in-depth patient-based case study.

Published By Datamonitor
15 Dec 2010 $6400
Buy
Report
Report

Commercial Insight: Inflammatory Bowel Disease - Future market prospects rely on addressing cost and safety

Coverage of the inflammatory bowel disease (IBD) market, including indication-specific 10-year forecasts, detailed brand profiling, opportunities and threats, and a scenario-based case study.

Published By Datamonitor
05 Aug 2010 $15200
Buy

Order this report by the 10th September 2010 and receive a 15% discount

To take advantage of this offer enter Promo Code opioid15 when prompted in the checkout

More information

Report
Report

Commercial Insight: Opioids in Australia

In-depth overview and 10 year outlook for currently marketed and pipeline opioid products in Australia, examining both clinical and commercial factors driving product differentiation and uptake.

Published By Datamonitor
20 May 2010 $5700
Buy
Report
Report

Commercial Insight: Osteoporosis - Market players maximize revenue growth before the next challenging phase

Comprehensive analysis of the current and future osteoporosis drug market, with country-specific forecasts to 2019 of marketed, generic, and key pipeline drugs in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).

Published By Datamonitor
21 Jul 2010 $15200
Buy
Report
Report

Competitive Trends in Global Wealth Management 2011

This report discusses the competitive conditions in the wealth management market and analyzes the main trends in competitive behavior over the last year and forecasts their impact on 2011.

Published By Datamonitor
17 Mar 2011 $5250
Buy
Report
Report

Competitor Market Shares and Developments in the Australian Payment Card Market

An up-to-date analysis of competitor market shares and dynamics in the Australian credit, debit, and charge card markets, looking at key competitor developments in the past 12 months.

Published By Datamonitor
08 Apr 2013 $3450
Buy

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

No help is available.